The Problem of Protocol Driven Costs in Pharmacoeconomic Analysis

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.14, Iss.4, 1998-10, pp. : 357-363

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Providing Systematic Guidance in Pharmacoeconomic Guidelines for Analysing Costs

By Jacobs Philip

PharmacoEconomics, Vol. 23, Iss. 2, 2005-01 ,pp. : 143-153

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic analysis of DPP-4 inhibitors

By Teramachi H. Ohta H. Tachi T. Toyoshima M. Mizui T. Goto C. Tsuchiya T.

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 11, 2013-11 ,pp. : 909-915

Govi-Verlag

Access to resources Recommend Favorite

A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency

By Staidle Jonathan P Dabade Tushar S Feldman Steven R

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 2041-2054

Informa Healthcare

Access to resources Recommend Favorite

Using Pharmacoeconomic Analysis to Make Drug Insurance Coverage Decisions

By Anis A.H. Rahman T. Schechter M.T.

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 119-126

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic Analysis of Antidepressants for Major Depressive Disorder in the United Kingdom

By Freeman H.

PharmacoEconomics, Vol. 18, Iss. 2, 2000-08 ,pp. : 143-148

Adis International

Access to resources Recommend Favorite